Primary Sclerosing Cholangitis in Children
A legfontosabb adatok
- Ki végzi
- Arbor Research Collaborative for Health
- Hol
- Atlanta, Aurora, Chicago, Cincinnati, Houston, Indianapolis, Los Angeles, Philadelphia, Pittsburgh, Salt Lake City és Seattle (Egyesült Államok)Mind a 11 helyszín megnézéseMég 1 másik országban, 1 helyszínen
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 1000 fő, tervezett
- Kezdés
- 2021. dec. 30.
- Várható befejezés
- 2029. máj. 31.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2026. július 14.
Ki vehet részt
- Életkor
- 2 év – 25 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 31 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with the clinical diagnosis of large or small duct PSC made at any time prior to enrollment are screened for eligibility to participate in this prospective cohort study. The site PI will determine eligibility following review of MRCP or ERCP images with the site radiologist to confirm presence of an abnormal cholangiogram at the time of diagnosis of large duct PSC. Liver histopathology obtained at the time of diagnosis of small duct PSC will be reviewed with the site pathologist prior to enrollment
- Individuals must meet all of the Inclusion criteria in order to be eligible to participate in the study:
- Aged 2 through 25 years at time of screening
- Diagnosis of large duct PSC based on review of cholangiogram by MRC, ERC, or intraoperative cholangiogram (IOC) by the site radiologist and interpreted to be consistent with PSC, based on one or more of the following:; Focal structuring of the bile duct(s); Dominant stricture of the common bile duct; Saccular dilatation of bile duct(s); Beaded appearance of bile duct(s); Pruning appearance of the distal bile duct branches; AND/OR
- Diagnosis of small duct PSC based on review of liver histopathology by the site pathologist and interpreted to be compatible with PSC:; Probable small duct PSC: biopsy with ≥3 of 5 criteria: periductal edema, concentric inflammation, bile duct injury, ductular reaction, and neutrophils in bile ducts (cholangitis) OR; Definitive small duct PSC: Periductal fibrosis/ "onion skinning" around interlobular bile ducts or smaller profiles
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Able to provide informed consent/assent; Participants for the imaging study are eligible if they are:
- Aged 8 through 25 years at the time of screening
- No absolute contraindication to MRI
- No skin condition that could be aggravated by MREL
- Meet all other eligibility criteria of the PSC Observational Study
- For whom none of the exclusion criteria apply
Ki nem vehet részt
- History bone marrow transplantation
- History of biliary tract surgery for cholecystolithiasis prior to cholangiogram/liver biopsy evaluated to determine enrollment
- Concurrent pregnancy at the time of enrollment -
- History of liver transplantation
- History of primary or acquired immunodeficiency predisposing to secondary sclerosing cholangitis, for instance: hyper-IgM syndrome, severe combined immunodeficiency (SCID) syndrome, common variable immunodeficiency (CVID) syndrome, cartilage hair hypoplasia syndrome, or HIV/AIDS
- History of histiocytosis, including Langerhans cell histiocytosis (LCH), or hemophagocytic lymphohistiocytosis (HLH)
- History of ischemic cholangitis
- History of portal vein thrombosis with biliopathy, veno-occlusive disease, or abdominal radiation vasculopathy
- History of recurrent pyogenic cholangitis
- History of biliary tract surgery for choledochal cyst
- History of hepatocellular carcinoma, or hepatoblastoma
- History of surgical biliary trauma
- History of congenital cytomegalovirus (CMV) hepatitis
- History of Sickle Cell Disease
- History of cystic fibrosis, biliary atresia, Caroli disease/congenital hepatic fibrosis, or progressive familial intrahepatic cholestasis type 3/MDR3 disease
- History of cardiac hepatopathy
- History of metabolic disorders, including Wilson's disease, glycogen storage disorder, Alpha-1 Antitrypsin deficiency
- An individual who meets any of the following criteria at baseline will be excluded from participation in this study
- Diagnosis of systemic lupus erythematosus (SLE)
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 2 és 25 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
Még 1 másik országban, 1 helyszínen
- Children's Healthcare of AtlantaAtlanta, Egyesült ÁllamokContact: Jordyn TurnerRésztvevőt keres
- Children's Hospital ColoradoAurora, Egyesült ÁllamokContact: Cynthia CastanonRésztvevőt keres
- Ann & Robert H. Lurie Children's HospitalChicago, Egyesült ÁllamokContact: Angela AnthonyRésztvevőt keres
- Cincinnati Children's Hospital MedicalCincinnati, Egyesült ÁllamokContact: Erin Chapman, BASRésztvevőt keres
- Texas Children's Hospital/ Baylor College of MedicineHouston, Egyesült ÁllamokContact: Alyia ThomasRésztvevőt keres
- Riley Hospital for ChildrenIndianapolis, Egyesült ÁllamokContact: Melissa Sexton, BBA, CCRPNo longer taking part
- Children's Hospital of Los AngelesLos Angeles, Egyesült ÁllamokContact: Sirikorn BoonsawatRésztvevőt keres
- The Children's Hospital Of PhiladelphiaPhiladelphia, Egyesült ÁllamokContact: Caitlin Griffiths, MSRésztvevőt keres
- UPMC Children's Hospital of PittsburghPittsburgh, Egyesült ÁllamokContact: Melissa Sexton, BBA, CCRPNo longer taking part
- The University of UtahSalt Lake City, Egyesült ÁllamokContact: Ann Rutherford, BS, CCRPRésztvevőt keres
- Seattle Children's HospitalSeattle, Egyesült ÁllamokContact: Melissa YoungRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Primary sclerosing cholangitis (PSC) is a rare liver disease that damages the liver's bile ducts. Bile ducts are tiny tubes that carry bile from the liver to the small intestine. Bile is a liquid produced by the liver that helps us absorb and use the nutrients in the food we eat. In people with PSC, the bile backs up into the liver and will damage it, causing scarring of the liver.
A teljes eredeti leírásKevesebb
The purposes of this study are to:
* Collect medical and other data to learn more about PSC, how it progresses, and identify factors that may cause the disease to progress more quickly. * Ask questions about how PSC symptoms affect your child's life to learn more about its impact on your child's daily functioning * Children with PSC who are seen at one of the participating clinical sites in the Childhood Liver Disease Research Network (ChiLDReN) will be asked to contribute information, DNA, and other specimens. The information and specimens will be available to investigators to carry out approved research aimed at learning more about the possible causes and long-term effects of PSC.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Prospective Observational Study of Primary Sclerosing Cholangitis (PSC) in Children
- Kérdések a feltételekről
- Forrás: NCT04181138: ki vehet részt
- A regiszteradat frissítve
- 2026. július 14.